Szostak MP - Search Results

1

Green fluorescent protein (GFP)-dependent separation of bacterial ghosts from intact cells by FACS.

Haidinger W, Szostak MP, Beisker W, Lubitz W. Haidinger W, et al. Among authors: szostak mp. Cytometry. 2001 Jun 1;44(2):106-12. Cytometry. 2001. PMID: 11378860

2

Online monitoring of Escherichia coli ghost production.

Haidinger W, Szostak MP, Jechlinger W, Lubitz W. Haidinger W, et al. Among authors: szostak mp. Appl Environ Microbiol. 2003 Jan;69(1):468-74. doi: 10.1128/AEM.69.1.468-474.2003. Appl Environ Microbiol. 2003. PMID: 12514029 Free PMC article.

3

Modulation of gene expression by promoter mutants of the lambdacI857/pRM/pR system.

Jechlinger W, Glocker J, Haidinger W, Matis A, Szostak MP, Lubitz W. Jechlinger W, et al. Among authors: szostak mp. J Biotechnol. 2005 Mar 2;116(1):11-20. doi: 10.1016/j.jbiotec.2004.10.002. Epub 2004 Nov 18. J Biotechnol. 2005. PMID: 15652426

4

Production of Vibrio cholerae ghosts (VCG) by expression of a cloned phage lysis gene: potential for vaccine development.

Eko FO, Szostak MP, Wanner G, Lubitz W. Eko FO, et al. Among authors: szostak mp. Vaccine. 1994 Oct;12(13):1231-7. doi: 10.1016/0264-410x(94)90249-6. Vaccine. 1994. PMID: 7530888

5

Bacterial ghosts: non-living candidate vaccines.

Szostak MP, Hensel A, Eko FO, Klein R, Auer T, Mader H, Haslberger A, Bunka S, Wanner G, Lubitz W. Szostak MP, et al. J Biotechnol. 1996 Jan 26;44(1-3):161-70. doi: 10.1016/0168-1656(95)00123-9. J Biotechnol. 1996. PMID: 8717400 Review.

6

Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines.

Mader HJ, Szostak MP, Hensel A, Lubitz W, Haslberger AG. Mader HJ, et al. Among authors: szostak mp. Vaccine. 1997 Feb;15(2):195-202. doi: 10.1016/s0264-410x(96)00141-7. Vaccine. 1997. PMID: 9066038

7

Bacterial ghosts as multifunctional vaccine particles.

Szostak MP, Mader H, Truppe M, Kamal M, Eko FO, Huter V, Marchart J, Jechlinger W, Haidinger W, Brand E, Denner E, Resch S, Dehlin E, Katinger A, Kuen B, Haslberger A, Hensel A, Lubitz W. Szostak MP, et al. Behring Inst Mitt. 1997 Feb;(98):191-6. Behring Inst Mitt. 1997. PMID: 9382740

8

Cold-sensitive E-lysis systems.

Jechlinger W, Szostak MP, Lubitz W. Jechlinger W, et al. Among authors: szostak mp. Gene. 1998 Sep 18;218(1-2):1-7. doi: 10.1016/s0378-1119(98)00405-3. Gene. 1998. PMID: 9751796

9

New strategies for combination vaccines based on the extended recombinant bacterial ghost system.

Eko FO, Witte A, Huter V, Kuen B, Fürst-Ladani S, Haslberger A, Katinger A, Hensel A, Szostak MP, Resch S, Mader H, Raza P, Brand E, Marchart J, Jechlinger W, Haidinger W, Lubitz W. Eko FO, et al. Among authors: szostak mp. Vaccine. 1999 Mar 26;17(13-14):1643-9. doi: 10.1016/s0264-410x(98)00423-x. Vaccine. 1999. PMID: 10194817 Review.

10

Altered temperature induction sensitivity of the lambda pR/cI857 system for controlled gene E expression in Escherichia coli.

Jechlinger W, Szostak MP, Witte A, Lubitz W. Jechlinger W, et al. Among authors: szostak mp. FEMS Microbiol Lett. 1999 Apr 15;173(2):347-52. doi: 10.1111/j.1574-6968.1999.tb13524.x. FEMS Microbiol Lett. 1999. PMID: 10227165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters